Precision medicine has the potential to cure diseases previously thought incurable. It has the potential to enhance the quality of life for millions of patients around the world who traditional medications simply aren’t working for. It has the potential to eliminate side-effects as each drug is tailored to a specific subset of individuals. Even Former President Obama showcased his belief in the potential when he announced the Precision Medicine Initiative (PMI) through the NIH.
The US Government took its support for Precision Medicine even further this past December, signing into law the 21st Century Cures Act , which makes provisions for more funding for the Precision Medicine Intiative , and other programs dedicated to advancing the use of technology in bettering healthcare across the board.
The question is, what's next?
Answering this is the objective for World Precision Medicine Congress USA in Washington, D.C. for 2017. This event is bringing together big pharma, big data, and healthcare providers to discuss the scientific, economic, and policy goals towards producing precise and genomic-based medicines.
By bringing these discussions together in one place, the World Precision Medicine Congress USA will be playing a vital role in seeing this paradigm played out to the end, with every major stakeholder taking part.